Large spine and orthopedic mergers have closed this year, and smaller device companies have sought to get their own slice of the pie during the third quarter.
Spinal Tech
The artificial disc replacement market is expexted to surpass $1.3 billion by 2030, according to Vantage Market Research.
Patrick Miles, CEO of Alphatec, sold 180,000 shares of the company for about $2.42 million, Seeking Alpha reported Sept. 20.
Carlsmed received its second FDA breakthrough device designation for Aprevo, the medtech company said Sept. 20.
ChoiceSpine recently received FDA clearance to market its Blackhawk Ti 3D-printed cervical spacer system.
Advertisement
Neuralink, Elon Musk's brain chip company, is recruiting for human trials, according to a Sept. 19 post on X, formerly known as Twitter.
Medical Metrics' Spine Camp platform earned FDA 510(k) clearance, the medtech company said Sept. 19.
Boston Scientific plans to acquire Relievant Medsystems, the company behind the Intracept intraosseous nerve ablation system.
Two spine surgeons with Plano-based Texas Back Institute debuted DeGen Medical's Solar AM implant, the medtech company said Sept. 18.
Becker's reported on two key spine and orthopedic recalls so far this year.